Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles2 certified filings for “Statistical Science Associate Director” (Statisticians) in DE: $205k–$209k, median $207k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles
- 2 certified filings for “Statistical Science Associate Director” (Statisticians) in DE: $205k–$209k, median $207k. Most were filed at wage level I (50%) — 1 lottery entry, ≈15% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
WHY JOIN US?
Evinova is a health-tech business focused on accelerating better health outcomes by advancing digital transformation across the life sciences sector. By combining science-based expertise, evidence-led rigor, and deep human insight, we design digital solutions that enable healthcare to work better for everyone.
Operating at the intersection of healthcare, technology, data, and analytics, we are helping unlock the full potential of digital health, transforming how clinical research is conducted, how care is delivered, and how patients experience healthcare. Our solutions are built to scale, driving efficiency, improving decision-making, and ultimately delivering better outcomes for patients worldwide.
At Evinova, we are driven by a shared purpose to transform health through data and digital innovation. Our teams collaborate across disciplines to solve complex challenges, continuously learning and evolving in a fast-paced, high-impact environment.
We also recognize the importance of flexibility and balance. Our ways of working support both individual needs and team collaboration. To foster connection and collaboration, employees are expected to work from the office three days per week , creating opportunities for in-person teamwork, innovation, and meaningful connection.
This is a hybrid position and requires on-site attendance 3 days per week.
What you'll do
As the Digital Science, Patient and Device Safety Director , you will set the scientific direction for, and hold oversight of, the scoping, design, development, testing and performance documentation of new digital solutions supporting clinical development – ensuring each solution is scientifically defensible, safe for the patients who use it, compliant with the applicable regulatory framework, user-centred and effective in sustaining engagement. Here are some key responsibilities you might have:
1. Innovation Strategy, Portfolio Oversight and Concept Definition:
• Own the innovation roadmap for patient-, care-partner- and HCP-facing digital solutions, setting scientific direction and prioritisation across the portfolio and securing endorsement at Evinova and R&D governance forums.
• Provide scientific oversight of the concept-to-commitment gate, holding teams to a consistent standard of intended-use definition, evidence expectation, safety consideration and regulatory positioning before investment decisions are taken.
• Identify and prioritise opportunities for new digital functionalities or products (e.g. RPM module, dosing diary, etc), working from disease and treatment landscape analysis, toxicity profiles, clinical guidelines, unmet monitoring needs and portfolio strategy.
• Define the intended use, target population, decision context and value proposition for each proposed solution, and articulate these in concept documents, business cases and stakeholder-facing materials.
• Assess build-versus-adopt options by evaluating existing instruments, item libraries, devices and sensors against the intended use before proposing de novo development.
2. Scientific Oversight of Instrument, Algorithm and Functionality Development:
• Lead the development of new measurement content and modules – item selection or de novo/bespoke item drafting, recall windows, response scales, branching logic, assessment frequency and burden optimisation.
• Specify scoring algorithms, thresholds, alerting rules and escalation pathways, and define how outputs are surfaced to patients, care-partners, site personnel and treating physicians.
• Translate scientific requirements into clear specifications and user stories for Product, Design and Engineering, and review builds against intent through configuration and testing cycles.
• Set and enforce the design standards applied ac
Apply on employer site ↗